Mirna Chehade, MD, MPH, discusses the challenges faced by patients with eosinophilic esophagitis (EoE), including the absence of predictive factors for personalized treatment, the social implications ...

Treatment with dupilumab demonstrated improvements in histological markers, symptoms, and endoscopic markers of eosinophilic esophagitis (EoE) regardless of previous history of esophageal dilation. In ...

The US Food and Drug Administration approvals of dupilumab (Dupixent, Regeneron/Sanofi) for adults and children with eosinophilic esophagitis (EoE) affirmed the safety and efficacy of the drug, which ...

Please provide your email address to receive an email when new articles are posted on . Ten of 13 patients on OIT who developed eosinophilic esophagitis continued treatment. EoE treatment included ...

Please provide your email address to receive an email when new articles are posted on . Over the years, there have been many advances in the pathologic understanding of eosinophilic esophagitis, but ...

If approved, Dupixent would be the first and only treatment in the U.S. indicated for children aged 1 to 11 with EoE, a disease driven by type 2 inflammation that impacts the ability to eat Of the ...

PHILADELPHIA (WPVI) -- Allergic reactions come in all varieties. One can even trigger a digestive disease which makes it hard to swallow. It's known as EOE - Eosinophilic Esophagitis. For more than 30 ...

Rationale To date, the exact significance of esophageal eosinophilia requires careful clinical consideration. Traditionally, this finding has been attributed solely to peptic injury, but with the ...

Eliminating animal milk alone from the diet of adults with eosinophilic esophagitis, or EoE, is as effective at treating the disease as eliminating animal milk plus five other common foods, a clinical ...

VICTORIA, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its ...